U.S. Army Captain Michael Kelvington, commander of the Battle company, 1-508 Parachute Infantry battalion, 4th Brigade Combat Team, 82nd Airborne Division, bows next to remains of Gulam Dostager, a member of Afghan Local Police who was killed in the blast of an Improvised Explosive Device (IED) during the joint Tor Janda (Black Flag in Pashtu) operation, in Zahri district of Kandahar province, southern Afghanistan May 25, 2012.  REUTERS/Shamil Zhumatov  (AFGHANISTAN - Tags: MILITARY CIVIL UNREST CONFLICT TPX IMAGES OF THE DAY)

Reuters Photojournalism

Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography.  See more | Photo caption 

Members of the U.S. Navy Blue Angels fly over the World Trade Center in lower Manhattan as part of the 25th annual Fleet Week celebration in New York, May 23, 2012.  REUTERS/Eduardo Munoz (UNITED STATES - Tags: MILITARY ANNIVERSARY TPX IMAGES OF THE DAY)

Fleet Week

The U.S. Navy takes Manhattan for a week.  Slideshow 

Photo

The SpaceX mission

A privately owned unmanned rocket blasts off on a mission to be the first commercial flight to the International Space Station.  Slideshow 

Poll shows worry about swine flu shot persists

Related Topics

An H1N1 flu vaccine inoculation is given at the Geisinger Medical Center in Danville, Pennsylvania October 28, 2009. REUTERS/Brad Bower

An H1N1 flu vaccine inoculation is given at the Geisinger Medical Center in Danville, Pennsylvania October 28, 2009.

Credit: Reuters/Brad Bower

WASHINGTON | Tue Dec 22, 2009 2:42pm EST

WASHINGTON (Reuters) - Americans who were worried about the safety of the swine flu vaccine are still worried and it may not be easy to convince them to get themselves or their children vaccinated, researchers said on Tuesday.

About 60 percent of parents polled say they plan to get their children vaccinated and 79 percent of adults will try to get the vaccines for themselves, but there is a hard core of resistance that has not been moved by entreaties by the U.S. government, pollsters said.

"Thirty-five percent of parents say they are not going to get it and 60 percent say the major reason is safety," Robert Blendon of the Harvard School of Public Health said in a telephone interview. "Our view is there just has to be more work on understanding how people think about the vaccine."

Several studies have shown the H1N1 swine flu vaccine does not cause unusual side effects and Blendon said it is not clear why so many parents are fearful.

The poll of 1,637 people aged 18 and older was taken last week, as 100 million vaccine doses had become available.

The U.S. Centers for Disease Control and Prevention estimates that nearly 50 million Americans have been infected with swine flu and 10,000 have been killed by it.

While this is not as high as the usual 36,000 deaths from seasonal influenza, officials note that swine flu infects and kills young adults and children more than seasonal flu does.

CONTINUED PUSH

The U.S. Health and Human Services Department has contracts with five companies to make 251 million doses of H1N1 vaccine.

The Harvard poll, which had an error margin of 3 percentage points, found that only 14 percent of adults had gotten the vaccine for themselves, but 79 percent would try to -- down from 92 percent who said they would in November.

HHS and CDC are working to get the vaccine distributed in so-called big box stores such as Wal-Mart.

John Roehm of Mollen Immunization Clinics, which operates the Wal-Mart clinics, said the company would have swine flu clinics in 48 states by the end of next week.

"We will see how demand is," Roehm said in a telephone interview. He said demand rose as state health departments encouraged the wider population to be vaccinated.

Retail drug stores have also begun administering vaccines, with Walgreen Co offering it at more than 1,500 locations in 27 U.S. states and CVS Caremark Corp in 20 states and Washington. Rite Aid had clinics in 12 states.

We welcome comments that advance the story through relevant opinion, anecdotes, links and data. If you see a comment that you believe is irrelevant or inappropriate, you can flag it to our editors by using the report abuse links. Views expressed in the comments do not represent those of Reuters. For more information on our comment policy, see http://blogs.reuters.com/fulldisclosure/2010/09/27/toward-a-more-thoughtful-conversation-on-stories/
Comments (3)
JanieC wrote:
Dec 22, 2009 3:25pm EST  --  Report as abuse
JanieC wrote:
I’m one of the “not at risk” population but did get a swine flu vaccine when our supply was opened up. I had fewer side effects (actually none) than my seasonal flu shot. I don’t get the fear. It’s been explained that this is no different than a seasonal flu shot — just tailored for swine flu. I did get it from my personal physician as I figured if there were a problem with the particular batch she had, I would know about it immediately.

Dec 22, 2009 3:28pm EST  --  Report as abuse
OGolly wrote:
Let me educate you, JanieC. I am one of the ‘uninformed’ and ‘hard core’ Americans who will NOT be getting a flu shot. “Uninformed?” Hardly. I’m a veteran Medical Service Corps officer of the U.S. Army who, like many other health care professionals, know enough NOT to trust the propaganda of the major drug cartels (the “legal”ones), the government and state run media like Reuters.

It doesn’t take a rocket scientist to do a cursory bit of research on his or her own that will quickly contradict the pablum being spouted by government funded research agencies. The PROVEN side effects of vaccines are numerous. Most H1N1 vaccine contains MANY TIMES OVER the amount of mercury exposure allowed a child in an entire lifetime. I am aware of at least three MAJOR RECALLS of the vaccines from makers for safety and health reasons.

Wake up and smell the coffee, folks. The major drug companies and elitists now running the government are NOT our friends.

Dec 23, 2009 3:11am EST  --  Report as abuse
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.